|
Dana-Farber, a world-renowned cancer institute, and Oracle, the world's largest enterprise software company, have joined forces in an ambitious effort to merge genomic information with clinical data as a step toward improving cancer diagnosis and individualizing treatment for patients. Oracle's US$1 million Commitment Grant will support Dana-Farber's efforts to bring a new approach to managing medical research information—ultimately, creating powerful tools that will increase the understanding of human cancers and lead to better ways to diagnose and treat this disease.
| 
